Developers all over the world are working on repurposing old drugs and creating new ones to treat COVID-19, and some could be ready by April this year.
The COVID-19 coronavirus is a respiratory virus, which means it can invade your respiratory system, affecting how you breathe in oxygen and get it to your bloodstream.
Professor Jonathan Heeney explains why we need a vaccine against the new COVID-19 coronavirus and how his team is using new technology developed for influenza and Ebola viruses to target the new infection.
After being exposed to the virus that causes COVID-19, it can take as few as two and as many as 14 days for symptoms to develop. Cases range from mild to critical.